| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/00044011-200323110-00005 |
| P698 | PubMed publication ID | 17536886 |
| P2093 | author name string | Christof Schöfl | |
| Georg Lübben | |||
| P2860 | cites work | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group | Q31976463 | ||
| Safety profile of pioglitazone | Q34396852 | ||
| The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review | Q34432672 | ||
| A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus | Q34479133 | ||
| Pioglitazone: a review of Japanese clinical studies. | Q34568207 | ||
| Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records | Q34599640 | ||
| Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect | Q35750683 | ||
| Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice | Q43649896 | ||
| Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study | Q43670632 | ||
| A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone | Q43937023 | ||
| Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada | Q44010115 | ||
| Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy | Q44034689 | ||
| Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes: a double-blind, placebo-controlled study | Q44221597 | ||
| Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study | Q44238610 | ||
| Economic costs of diabetes in the US in 2002. | Q44892463 | ||
| Revealing the cost of Type II diabetes in Europe | Q50110273 | ||
| The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. | Q50698468 | ||
| Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. | Q51552529 | ||
| The continuing epidemics of obesity and diabetes in the United States | Q56890709 | ||
| A Desktop Guide to Type 1 (Insulin-dependent) Diabetes Mellitus: European Diabetes Policy Group 1998, International Diabetes Federation, European Region | Q77477259 | ||
| P433 | issue | 11 | |
| P921 | main subject | insulin resistance | Q1053470 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 725-734 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice. | |
| P478 | volume | 23 |
Search more.